文献速递基础与转化研究

肝巨噬细胞TIM4介导的胞葬作用受损促进代谢功能障碍相关脂肪性肝炎纤维化

Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction-associated steatohepatitis.
PubMed 文献 · Sci Transl Med · 2025-09-10

在人类和小鼠代谢功能障碍相关脂肪性肝炎(MASH)模型中,凋亡肝细胞蓄积与肝巨噬细胞胞葬作用受损及TIM4表达缺失相关。中和抗TIM4抗体或Kupffer细胞Timd4基因敲除可减少胞葬、增加促纤维化肝星状细胞活化并加速纤维化MASH进展;恢复巨噬细胞Timd4或输注TIM4+巨噬细胞可增强凋亡肝细胞清除并减轻肝纤维化。胞葬巨噬细胞通过分泌IL-10使肝星状细胞失活。

要点

  • 人类和小鼠MASH中凋亡肝细胞蓄积,伴肝巨噬细胞胞葬作用受损和TIM4缺失。
  • 阻断TIM4减少胞葬、增加肝星状细胞促纤维化活化并加速纤维化MASH进展。
  • 恢复巨噬细胞Timd4或TIM4+巨噬细胞治疗可增强清除并减轻肝纤维化。

核心结论

  • MASH中肝巨噬细胞TIM4表达降低导致胞葬作用受损,促进肝纤维化进展。
  • 恢复巨噬细胞TIM4或TIM4+巨噬细胞治疗可增强凋亡肝细胞清除并减轻肝纤维化。
  • 胞葬巨噬细胞通过分泌IL-10使肝星状细胞失活。

研究设计与样本

  • 研究使用喂食果糖-棕榈酸-胆固醇(FPC)饮食或高脂、缺乏胆碱氨基酸定义(HF-CDAA)饮食的小鼠MASH模型。
  • 研究使用人类MASH样本和离体巨噬细胞-肝星状细胞交互模型。

主要发现

  • 人类和小鼠MASH中凋亡肝细胞蓄积,与胞葬作用受损和TIM4缺失相关。
  • 在FPC和HF-CDAA饮食喂养小鼠中,给予中和抗TIM4抗体或Kupffer细胞Timd4基因敲除减少肝巨噬细胞胞葬作用,增加产胶原肝星状细胞的促纤维化活化,并加速纤维化MASH进展。
  • 在FPC和HF-CDAA饮食喂养MASH小鼠中,恢复巨噬细胞Timd4或TIM4+巨噬细胞细胞治疗增强凋亡肝细胞清除,减少肝星状细胞活化和肝纤维化。
  • 离体巨噬细胞-肝星状细胞交互模型和HF-CDAA MASH模型显示,胞葬巨噬细胞通过重编程分泌IL-10使肝星状细胞失活,IL-10激活肝星状细胞上的IL-10受体以抑制其促纤维化活化。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatocyte apoptosis is a key feature of metabolic dysfunction-associated steatohepatitis (MASH), but the fate of apoptotic hepatocytes in MASH is poorly understood. Here, we explore the hypotheses that clearance of dead hepatocytes by liver macrophages (efferocytosis) is impaired in MASH because of low expression of the efferocytosis receptor T cell immunoglobulin and mucin domain containing 4 (TIM4; gene Timd4) by MASH liver macrophages, which then drives liver fibrosis in MASH. We show that apoptotic hepatocytes accumulate in human and experimental MASH, using mice fed the fructose-palmitate-cholesterol (FPC) diet or the high-fat, choline-deficient amino acid-defined (HF-CDAA) diet. Apoptotic hepatocyte accumulation is associated with impaired efferocytosis and loss of TIM4. Administration of neutralizing anti-TIM4 antibodies or genetic deletion of Timd4 in Kupffer cells of FPC and HF-CDAA diet-fed mice decreased efferocytosis by liver macrophages, increased profibrotic activation of collagen-producing hepatic stellate cells (HSCs), and accelerated the progression to fibrotic MASH. Genetic restoration of macrophage Timd4 in FPC and HF-CDAA diet-fed MASH mice or cell therapy with TIM4+ macrophages enhanced apoptotic hepatocyte clearance and decreased HSC activation and liver fibrosis. Studies using an ex vivo macrophage HSC cross-talk model and the HF-CDAA MASH model revealed that inactivation of HSCs by efferocytosing macrophages involved macrophage reprogramming to secrete interleukin-10 (IL-10), which activated the IL-10 receptor on HSCs to dampen their profibrotic activation. These findings reveal a key process in the progression from hepatic steatosis to early MASH fibrosis and identify a mechanism-based therapeutic strategy to prevent fibrotic MASH progression.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Shi H, Wang X, Sloas C, et al. Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction-associated steatohepatitis. Sci Transl Med. 2025. PMID: 40929246. doi:10.1126/scitranslmed.adv2106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。